How to Help Your Patients Save Money on Lomaira: A Provider's Guide to Savings Programs

For many patients managing obesity with Lomaira (phentermine hydrochloride 8 mg), medication cost is a real barrier. At an average retail price of approximately $70 for 30 tablets, Lomaira is far more affordable than GLP-1 injectables — but still a meaningful expense for patients without adequate insurance coverage. As the prescribing provider, you play a critical role in helping patients access savings programs, navigate insurance, and find lower-cost pathways to their medication. This guide equips your clinical team with the resources and workflow strategies to make that happen.

Understanding the Lomaira Cost Landscape

Providers should understand that the retail cash price is rarely what patients pay. Multiple programs exist that can bring the monthly cost of Lomaira to $15–$45 depending on supply quantity. Here is the current pricing landscape for 2026:

• Retail cash price: ~$70 for 30 tablets (8 mg) at most pharmacies without any savings card or insurance
• Lomaira Lo-Cost Access Program: Up to $0.50/tablet — $15 for 30 tablets, $45 for 90 tablets (manufacturer program by KVK Tech)
• GoodRx: As low as ~$17 for 30 tablets at participating pharmacies (state restrictions apply for controlled substances)
• SingleCare: ~$26 for 30 tablets at participating pharmacies
• Insurance (commercial): Most non-ACA commercial plans cover phentermine; copays typically $5–$50 depending on tier and plan; prior auth or step therapy often required

The Lomaira Lo-Cost Access Program: Your Most Powerful Patient Resource

The Lomaira Lo-Cost Access Program, offered by manufacturer KVK Tech, is the single most effective savings tool for most Lomaira patients. Clinical teams should be familiar with its details so they can counsel patients accurately:

• Cost cap: No more than $0.50 per tablet for the duration of treatment
• Duration: Valid for the entire treatment course — no time limit listed
• Insurance requirement: No insurance required; available to uninsured patients
• Medicare note: Medicare Part D patients may use the card at cash price, but cannot apply costs toward Medicare TrOOP. Not valid for prescriptions reimbursed in full by any third-party payer.
• Minimum quantity: 30 tablets per fill
• How to register: Visit lomaira.com/money-saving-offer/ or call 1-844-566-2472; download or print the savings card and present at the pharmacy

Insurance Coverage Navigation: What Prescribers Need to Know

Insurance coverage for Lomaira and phentermine varies substantially by plan type and state. Here is a summary of the landscape for clinical teams:

• Commercial/employer plans (non-ACA): Most cover phentermine as a Tier 2 or Tier 3 medication. Lomaira brand may require a prior authorization or step therapy (requiring the patient try generic phentermine first). Know that if step therapy is required, a successful prior authorization appeal may be possible with documentation of clinical need for the 8 mg TID formulation specifically (e.g., patient's sensitivity to higher doses or need for meal-targeted dosing).
• ACA marketplace plans: Coverage varies by insurer and state. ACA plans are not required to cover weight-loss medications, but many do.
• Medicaid: Approximately half of state Medicaid programs cover phentermine. Lomaira brand may or may not be on formulary — check the state's Medicaid PDL (preferred drug list). Generic phentermine at higher doses may be covered even when Lomaira is not.
• Medicare Part D: Almost universally excluded. Medicare Part D plans are not required to cover weight-loss medications, and nearly all exclude them. Advise Medicare patients to use the Lo-Cost Access Program or a discount card (subject to state restrictions on controlled substance cards).

Prior Authorization: When and How to Appeal

When a commercial insurer requires a prior authorization for Lomaira brand (vs. generic phentermine), the process typically requires:

1. Documentation of clinical indication — BMI ≥30 or ≥27 with comorbidities, documented attempt at non-pharmacologic weight management
2. If step therapy applies: documentation that generic phentermine was tried and the reason Lomaira's unique 8 mg TID formulation is specifically required (e.g., side effect profile, meal-timing flexibility, reduced stimulant load)
3. Submit the PA request through your EHR or insurer's portal. Most PA decisions for Schedule IV controlled substances come within 72 hours.

If the PA is denied: a peer-to-peer appeal with the plan's medical director can be effective, particularly if you can articulate why the brand formulation is clinically preferred for the specific patient.

Discount Card Considerations for Controlled Substances

An important nuance: several states prohibit or restrict the use of third-party pharmacy discount cards (GoodRx, SingleCare, WellRx, etc.) on Schedule II, III, and IV controlled substance prescriptions. States with known restrictions include New York, New Jersey, and others. If a patient reports that GoodRx isn't being accepted at their pharmacy for Lomaira, this may be the reason. In such cases, the Lomaira Lo-Cost Access Program (manufacturer-sponsored) is typically unaffected by these restrictions since it is not a third-party discount card.

Workflow Integration: Savings Counseling at the Point of Prescribing

The most cost-effective savings interventions happen at the time of prescribing, before the patient goes to the pharmacy. Consider embedding the following into your Lomaira prescribing workflow:

1. Ask every new Lomaira patient: "Do you have insurance that covers weight-loss medications?" and check quickly or ask staff to verify.
2. For patients without coverage or with high copays, proactively share the Lomaira Lo-Cost Access Program website (lomaira.com/money-saving-offer/) or have printed program cards available in the office.
3. Write for 90-day supplies where permitted — reduces per-tablet cost with the Lo-Cost Program to ~$45 total vs. $15 per 30-day fill.
4. For commercial insurance patients facing prior auth, start the PA process the day you prescribe — don't wait for a patient callback about a denied fill.

How medfinder Helps Your Cost-Constrained Patients

Cost and availability are often intertwined barriers. A patient who has found a great savings program still needs to find a pharmacy that stocks Lomaira. medfinder is a paid service that contacts pharmacies near the patient's location to find which ones can fill their prescription. For practices serving patients with both access and cost challenges, recommending medfinder as a first step — before the prescription is sent — helps patients identify the right pharmacy before encountering stock problems.

Summary: Provider Checklist for Lomaira Cost Management

• Share the Lomaira Lo-Cost Access Program with every new patient (lomaira.com/money-saving-offer/)
• Write 90-day prescriptions where state law and clinical judgment permit
• Check your state's rules on discount card use for Schedule IV controlled substances before recommending GoodRx
• Initiate prior authorization early when commercial insurance coverage is expected
• Advise Medicare patients that Part D coverage is not available — Lo-Cost Access Program is primary option
• Recommend medfinder for patients experiencing difficulty both finding and affording Lomaira

For a broader clinical guide to helping patients access Lomaira, see: How to help your patients find Lomaira in stock: a provider's guide